JP2005500271A5 - - Google Patents

Download PDF

Info

Publication number
JP2005500271A5
JP2005500271A5 JP2003500075A JP2003500075A JP2005500271A5 JP 2005500271 A5 JP2005500271 A5 JP 2005500271A5 JP 2003500075 A JP2003500075 A JP 2003500075A JP 2003500075 A JP2003500075 A JP 2003500075A JP 2005500271 A5 JP2005500271 A5 JP 2005500271A5
Authority
JP
Japan
Prior art keywords
compound
agent
article
conjugate
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003500075A
Other languages
English (en)
Other versions
JP4554198B2 (ja
JP2005500271A (ja
Filing date
Publication date
Priority claimed from GBGB0113121.8A external-priority patent/GB0113121D0/en
Application filed filed Critical
Publication of JP2005500271A publication Critical patent/JP2005500271A/ja
Publication of JP2005500271A5 publication Critical patent/JP2005500271A5/ja
Application granted granted Critical
Publication of JP4554198B2 publication Critical patent/JP4554198B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Claims (23)

  1. 下記の式Iのフェノチアジニウム化合物:
    Figure 2005500271
    (式中、AおよびBは、各々個々に、
    Figure 2005500271
    であり、ZはCH2、O、S、SO2、HN、NCH3、NC2H5、NCH2CH2OHまたはNCOCH3であり、R1およびR2は、各々個々に、線状または枝分れのCnH2nYであり、nは1〜6であり、YはH、F、Cl、Br、I、OH、OCH3、OC2H5、OC3H7、CNまたはOCOCH3であり;
    XP-はカウンターアニオンであり、Pは1、2または3である;
    但し、AおよびBの双方が-N(CH3)2または-N(CH2CH3)2のいずれかである化合物は含まない)。
  2. 前記カウンターアニオンが、Cl-、Br-、I-、F-、NO3 -、HSO4 -、CH3CO2 -のいずれか;ジアニオン、即ち、SO4 2-またはHPO4 2-;またはトリアニオン、即ち、PO4 3-から選ばれる、請求項1記載の化合物。
  3. AおよびBが同一であり、R1およびR2の双方がn-プロピル、n-ブチルまたはn-ペンチルである、請求項1記載の化合物。
  4. 請求項1〜3のいずれか1項記載の化合物を含有する抗微生物剤
  5. 細菌に対して使用するための、請求項4記載の抗微生物剤
  6. 抗生剤耐性菌に対して使用するための、請求項4または5記載の抗微生物剤
  7. 請求項1〜3のいずれか1項記載の化合物を含有するPDT剤または光診断剤
  8. 請求項1〜3のいずれか1項記載の化合物を含有する医薬組成物
  9. 皮膚および他の局所感染症の抗菌治療として、熱傷創および他の病変の滅菌用、および歯科細菌疾患の治療用に使用するための、請求項8記載の医薬組成物
  10. 前がん症状;がん;黄斑変性症のような眼科疾患;心臓血管疾患、動脈硬化症および再狭窄のような血管問題;リウマチ様関節炎のような自己免疫疾患;乾癬、にきびおよびセメント質化症のような皮膚疾患;並びに子宮内膜症および月経過多のような他の良性症状の治療において使用するための、請求項8記載の医薬組成物
  11. 表面または流体の滅菌用の光活性化抗菌剤として使用するための、請求項4記載の抗微生物剤
  12. 光化学内在化において使用するための、請求項7記載のPDT剤又は光診断剤
  13. 光検出および/または光診断において使用するための、請求項7記載のPDT剤又は光診断剤
  14. 請求項1〜13のいずれか1項記載の化合物とポリマー間で形成された接合体または複合体。
  15. 前記ポリマーが無水物および/またはエステル基を含む、請求項14記載の接合体または複合体。
  16. 請求項1〜13のいずれか1項記載の化合物とクロロトリアジン誘導体との反応によって形成される化合物。
  17. 前記クロロトリアジン誘導体が結合クロロトリアジン基を有するポリマーである、請求項16記載の化合物。
  18. 請求項1〜17のいずれか1項記載の化合物、接合体または複合体を希釈剤または賦形剤と一緒に含む組成物。
  19. 表面または流体の滅菌方法であって、前記表面または流体に請求項1〜3のいずれか1項記載の化合物を適用し、前記化合物を光によって活性化させることを特徴とする滅菌方法。
  20. 請求項1〜3のいずれか1項記載の化合物、接合体または複合体を結合させた少なくとも1つの表面を有する物品。
  21. 結合が共有結合または分子間相互作用による、請求項20記載の物品。
  22. 医療器具である、請求項20または21記載の物品。
  23. 食品工業において使用する、請求項20または21記載の物品。
JP2003500075A 2001-05-30 2002-05-30 生物学的に活性なメチレンブルー誘導体 Expired - Fee Related JP4554198B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0113121.8A GB0113121D0 (en) 2001-05-30 2001-05-30 Biologically active photosensitisers
GBGB0123945.8A GB0123945D0 (en) 2001-05-30 2001-10-05 Biologically active photosensitisers
PCT/GB2002/002278 WO2002096896A1 (en) 2001-05-30 2002-05-30 Biologically active methylene blue derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009160062A Division JP2009280588A (ja) 2001-05-30 2009-07-06 生物学的に活性なメチレンブルー誘導体

Publications (3)

Publication Number Publication Date
JP2005500271A JP2005500271A (ja) 2005-01-06
JP2005500271A5 true JP2005500271A5 (ja) 2006-01-05
JP4554198B2 JP4554198B2 (ja) 2010-09-29

Family

ID=26246135

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003500075A Expired - Fee Related JP4554198B2 (ja) 2001-05-30 2002-05-30 生物学的に活性なメチレンブルー誘導体
JP2009160062A Pending JP2009280588A (ja) 2001-05-30 2009-07-06 生物学的に活性なメチレンブルー誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009160062A Pending JP2009280588A (ja) 2001-05-30 2009-07-06 生物学的に活性なメチレンブルー誘導体

Country Status (21)

Country Link
US (6) US7371744B2 (ja)
EP (3) EP1790642A1 (ja)
JP (2) JP4554198B2 (ja)
KR (3) KR20090061684A (ja)
CN (2) CN101928262A (ja)
AT (1) ATE355282T1 (ja)
AU (1) AU2002256784B2 (ja)
BR (1) BR0209783A (ja)
CA (1) CA2448303C (ja)
CY (1) CY1108091T1 (ja)
DE (1) DE60218454T2 (ja)
DK (1) DK1392666T3 (ja)
ES (1) ES2280533T3 (ja)
GB (2) GB0113121D0 (ja)
HK (1) HK1063788A1 (ja)
MX (1) MXPA03010916A (ja)
NO (1) NO324321B1 (ja)
NZ (1) NZ529682A (ja)
PT (1) PT1392666E (ja)
WO (1) WO2002096896A1 (ja)
ZA (1) ZA200309215B (ja)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6283956B1 (en) 1998-11-30 2001-09-04 David H. McDaniels Reduction, elimination, or stimulation of hair growth
US9192780B2 (en) 1998-11-30 2015-11-24 L'oreal Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders
US6887260B1 (en) 1998-11-30 2005-05-03 Light Bioscience, Llc Method and apparatus for acne treatment
US20060212025A1 (en) * 1998-11-30 2006-09-21 Light Bioscience, Llc Method and apparatus for acne treatment
GB0113121D0 (en) 2001-05-30 2001-07-18 Univ Leeds Biologically active photosensitisers
US7368221B2 (en) * 2002-06-17 2008-05-06 Verification Technologies, Inc. Changing light absorption by disruption of conjugation
WO2004092335A2 (en) 2003-04-10 2004-10-28 Light Bioscience, Inc. Photomodulation methods and devices for regulating cell proliferation and gene expression
JP4739202B2 (ja) 2003-07-31 2011-08-03 ジェントルウェイブス エルエルシー 熱傷、創傷、および関連皮膚疾患の光力学治療のためのシステムおよび方法
US20050053895A1 (en) 2003-09-09 2005-03-10 The Procter & Gamble Company Attention: Chief Patent Counsel Illuminated electric toothbrushes emitting high luminous intensity toothbrush
GB0322756D0 (en) * 2003-09-29 2003-10-29 Univ Aberdeen Methods of chemical synthesis
JP2007512297A (ja) * 2003-11-28 2007-05-17 フォトファーマイカ リミテッド 生物活性メチレンブルー誘導体(2)における開発
US7326258B2 (en) 2004-06-18 2008-02-05 L'oreal S.A. Compositions comprising hydroxyalkyl direct dyes, implementation processes and uses thereof
BRPI0503921A (pt) * 2004-06-18 2006-07-18 Oreal composição cosmética, processos para tintura das fibras queratìnicas, processo para clareamento das fibras queratìnicas, dispositivo com múltiplos compartimentos, uso de composto hidroxialquilado e uso de uma composição de tintura
US8240312B2 (en) 2004-09-09 2012-08-14 Osnat Feuerstein Method and means for exerting a phototoxic effect of visible light on microorganisms
US20080166304A1 (en) * 2004-09-17 2008-07-10 The General Hospital Corpoartion Inactivation of Microorganisms With Multidrug Resistance Inhibitors and Phenothiaziniums
GB0420893D0 (en) 2004-09-20 2004-10-20 Photopharmica Ltd Photosensitisers and their uses
GB0420888D0 (en) * 2004-09-20 2004-10-20 Photopharmica Ltd Compounds and uses
PT1799662E (pt) 2004-09-23 2013-07-09 Wista Lab Ltd Métodos de síntese química e purificação de compostos de diaminofenotiazínio incluindo cloreto de metiltionínio (mtc)
CN101084204B (zh) * 2004-09-23 2012-12-05 卫思道制药有限公司 包括亚甲蓝(mtc)在内的二氨基吩噻嗪鎓化合物的化学合成和纯化方法
EP1810290A4 (en) * 2004-09-24 2010-04-21 Verification Technologies Inc MODIFICATION OF LIGHT ABSORPTION BY BREAK OF CONJUGATION
US7101997B2 (en) 2004-10-07 2006-09-05 Honeywell International Inc. Method for producing phenothiazinium compounds
US20060222592A1 (en) * 2005-04-05 2006-10-05 Clemens Burda Nanoparticles and methods of manufacturing nanoparticles for electronic and non-electronic applications
GB0602125D0 (en) * 2006-02-03 2006-03-15 Univ Belfast Sensitizer-incorporated biomaterials
US20070255357A1 (en) 2006-04-28 2007-11-01 Ondine International, Ltd. Nasal decolonization of microbes
DK2057136T3 (da) 2006-07-11 2013-08-26 Wista Lab Ltd Fremgangsmåde til syntese og/eller oprensning af diaminophenothiazinium forbindelser
US20080139991A1 (en) * 2006-12-08 2008-06-12 Ondine International, Ltd. Method of wound disinfecting and tissue welding
CA2686513C (en) * 2007-04-03 2017-06-13 Prosetta Bioconformatics Inc. Diamino-benzothiazine derivatives as antiviral agents
ES2562205T3 (es) * 2007-04-17 2016-03-03 Codman & Shurtleff, Inc. Hibrídos de curcumina resveratrol
US8383865B2 (en) * 2007-04-17 2013-02-26 Codman & Shurtleff, Inc. Curcumin derivatives
US20080269205A1 (en) * 2007-04-27 2008-10-30 Ondine International, Ltd. Methods to prevent vertical transmission of infectious diseases
US20090035725A1 (en) * 2007-08-02 2009-02-05 Ondine International, Ltd. Photodisinfection of oral cavity
US20090093470A1 (en) * 2007-10-08 2009-04-09 Ondine International, Ltd. Photodynamic therapy process and photosensitizer compositions therefor
KR20100138922A (ko) * 2008-02-13 2010-12-31 안드레아스 로즈 방사광 출력 패턴을 제공하는 광 전달장치
US7985776B2 (en) 2008-06-27 2011-07-26 Codman & Shurtleff, Inc. Iontophoretic delivery of curcumin and curcumin analogs for the treatment of Alzheimer's Disease
CN102112120B (zh) * 2008-08-01 2013-01-23 恩迪尼国际有限公司 用于处理mrsa的组合物和方法
WO2010036617A1 (en) * 2008-09-23 2010-04-01 Ondine International Holdings Ltd. Portable photodynamic disinfection light delivery device for catheter disinfection
MX2011003277A (es) * 2008-10-14 2012-09-21 Salubrious Pharmaceuticals LLC Proceso para el tratamiento de la artritis reumatoide, temblores/enfermedad de parkinson, esclerosis multiple y cancer de tipo no viral.
US20100286585A1 (en) * 2009-01-26 2010-11-11 Codman & Shurtleff, Inc. Shunt Delivery of Curcumin
US7723515B1 (en) * 2009-01-26 2010-05-25 Codman & Shurtleff, Inc. Methylene blue—curcumin analog for the treatment of alzheimer's disease
US20100256125A1 (en) * 2009-04-06 2010-10-07 Zila Pharmaceuticals, Inc. Use of improved toluidine blue in photodynamic therapy
CN102791297A (zh) * 2010-03-08 2012-11-21 诺瓦提斯公司 活性氧消毒系统及其用途
CN102958525B (zh) 2010-04-30 2017-05-24 普罗瑟塔抗病毒股份有限公司 抗病毒化合物
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
WO2012125983A1 (en) 2011-03-17 2012-09-20 Prosetta Antiviral Inc. Antiviral treatments
WO2012145567A1 (en) 2011-04-20 2012-10-26 Prosetta Antiviral Inc. Antiviral compounds
US20120301904A1 (en) 2011-04-26 2012-11-29 Prosetta Antiviral, Inc Multiprotein assemblies
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
CA2851344C (en) * 2011-09-05 2017-10-03 Hiroshi Maeda Polymer-type fluorescent molecule probe
US9345573B2 (en) 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
AU2013341383B2 (en) 2012-11-12 2017-08-24 The Roger B. And Ann K. Mcnamee Trust U/T/A/D Systems and methods for communicating a live event to users using the internet
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
WO2016069556A2 (en) 2014-10-29 2016-05-06 University Of Maryland Methods of treating age-related symptoms in mammals and compositions therefor
CA2966010C (en) * 2014-10-31 2023-04-11 Klox Technologies Inc. Photoactivatable fibers and fabric media
JP6743041B2 (ja) * 2015-03-30 2020-08-19 タリス バイオメディカル エルエルシー 上部尿路への薬剤の局所的な送達装置及び方法
CN106901871B (zh) * 2015-12-23 2021-08-24 爱博诺德(北京)医疗科技股份有限公司 具有一个或多个附加部分的人工晶状体
CN108882981B (zh) 2016-01-29 2021-08-10 内奥瓦斯克迪亚拉公司 用于防止流出阻塞的假体瓣膜
US10189862B2 (en) 2016-06-14 2019-01-29 The Chinese University Of Hong Kong Phenothiazine-pyridine compounds and uses thereof
CN109996581B (zh) 2016-11-21 2021-10-15 内奥瓦斯克迪亚拉公司 用于快速收回经导管心脏瓣膜递送系统的方法和系统
US11413240B2 (en) 2016-12-29 2022-08-16 Board Of Regents, The University Of Texas System Methylene blue solution for the treatment of oral lesions
KR101988240B1 (ko) * 2017-02-27 2019-06-12 주식회사 디알나노 피부질환에 사용되는 메틸렌 블루 복합체 및 이의 용도
WO2019032683A2 (en) * 2017-08-08 2019-02-14 Board Of Trustees Of Michigan State University LIGHT-EMITTING ORGANIC SALTS FOR ENHANCED PHOTODYNAMIC THERAPY AND IMAGING
CA3073834A1 (en) 2017-08-25 2019-02-28 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
AU2019374743B2 (en) 2018-11-08 2022-03-03 Neovasc Tiara Inc. Ventricular deployment of a transcatheter mitral valve prosthesis
US11998447B2 (en) 2019-03-08 2024-06-04 Neovasc Tiara Inc. Retrievable prosthesis delivery system
US11510876B2 (en) 2019-03-29 2022-11-29 Mayo Foundation For Medical Education And Research In vivo targeting of extracellular vesicles
CA3135753C (en) 2019-04-01 2023-10-24 Neovasc Tiara Inc. Controllably deployable prosthetic valve
CA3136334A1 (en) 2019-04-10 2020-10-15 Neovasc Tiara Inc. Prosthetic valve with natural blood flow
EP3972673A4 (en) 2019-05-20 2023-06-07 Neovasc Tiara Inc. INTRODUCER DEVICE WITH HEMOSTASIS MECHANISM
CA3143344A1 (en) 2019-06-20 2020-12-24 Neovasc Tiara Inc. Low profile prosthetic mitral valve
WO2023186737A1 (en) 2022-04-01 2023-10-05 Lllt Technologies Sa Photodynamic light therapy apparatus and methods for treating oral disease

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3579339A (en) 1967-05-23 1971-05-18 Du Pont Photopolymerizable dispersions and elements containing nonmigratory photoreducible dyes
US3641016A (en) * 1968-02-16 1972-02-08 Egyt Gyogyszervegyeszeti Gyar Thionine derivatives
US4001587A (en) * 1975-10-24 1977-01-04 Panchenkov Georgy Mitrofanovic Color indicator-dosimeter of ionizing radiation
JPS6020740B2 (ja) * 1976-07-14 1985-05-23 株式会社リコー カラ−像形成用感光材料
EP0128414A3 (en) 1983-06-06 1986-09-10 The Hilton - Davis Chemical Company Method of sanitizing toilets
US4622395A (en) * 1984-10-01 1986-11-11 Minnesota Mining And Manufacturing Company Phenoxazine and phenothiazine dyes and leuco forms thereof
DE3644369A1 (de) * 1986-12-24 1988-07-07 Basf Ag Verfahren zur uebertragung von kationischen farbstoffen in ihrer deprotonierten, elektrisch neutralen form
JPS63187154A (ja) 1987-01-29 1988-08-02 Kishida Kagaku Kk 酸素検知剤
DE3710282A1 (de) * 1987-03-28 1988-10-13 Hoechst Ag Photopolymerisierbares gemisch und daraus hergestelltes aufzeichnungsmaterial
US4844896A (en) * 1987-11-02 1989-07-04 Lim Technology Laboratories, Inc. Microencapsulated insecticidal pathogens
JP2879080B2 (ja) * 1989-03-23 1999-04-05 株式会社リコー 電界発光素子
US5270144A (en) * 1989-07-10 1993-12-14 Tomoegawa Paper Co., Ltd. Toner for developing static charge images
WO1991016911A1 (en) * 1990-05-01 1991-11-14 The American National Red Cross Decontamination of whole blood and cellular components by phenthiazin-5-ium-dyes plus light
US5545516A (en) 1990-05-01 1996-08-13 The American National Red Cross Inactivation of extracellular enveloped viruses in blood and blood components by phenthiazin-5-ium dyes plus light
US5220009A (en) * 1990-05-03 1993-06-15 Yeda Research And Development Company Limited Phenothiazinium salts and their use for disinfecting aqueous effluents
JPH05170752A (ja) * 1991-04-26 1993-07-09 Takeda Chem Ind Ltd 3,7−ビス(ジ置換アミノ)フェノチアジン誘導体およびその製造法
US5344928A (en) * 1991-04-26 1994-09-06 Takeda Chemical Industries, Ltd. Phenothiazine derivatives, their production and use
US5358876A (en) * 1991-07-17 1994-10-25 Mitsubishi Gas Chemical Company, Inc. Oxygen indicator
US5239405A (en) * 1991-09-06 1993-08-24 Donnelly Corporation Electrochemichromic solutions, processes for preparing and using the same, and devices manufactured with the same
US5611793A (en) * 1992-04-30 1997-03-18 Institute Of Dental Surgery Laser treatment
JP3690825B2 (ja) * 1993-07-26 2005-08-31 エーザイ株式会社 三環式ヘテロ環含有スルホンアミドおよびスルホン酸エステル誘導体
US5635059A (en) * 1994-10-20 1997-06-03 Aqua-Ion Systems, Inc. Method and apparatus for water treatment and purification using gas ion plasma source and disinfectant metal ion complexes
GB9506197D0 (en) 1995-03-27 1995-05-17 Hoffmann La Roche Inhibition of tau-tau association.
JPH08305026A (ja) * 1995-05-12 1996-11-22 Fuji Photo Film Co Ltd 画像記録方法
CA2214829C (en) * 1996-01-16 2002-05-14 Edwin Pomerantz Methods and compositions for in-vivo detection of oral cancers and precancerous conditions
DE19640758C2 (de) 1996-10-02 1999-11-04 Rafael Lachky Mittel zur Behandlung von Diskusfischen
CA2278245A1 (en) * 1997-01-21 1998-07-23 The American National Red Cross Intracellular and extracellular decontamination of whole blood and blood components by amphiphilic phenothiazin-5-ium dyes plus light
US20040055965A1 (en) * 1997-06-13 2004-03-25 Hubig Stephan M. Recreational water treatment employing singlet oxygen
US6251127B1 (en) * 1997-08-25 2001-06-26 Advanced Photodynamic Technologies, Inc. Dye treatment solution and photodynamic therapy and method of using same
US5811471A (en) * 1997-09-15 1998-09-22 Shanbrom Technologies Llc Disinfectant plastic sponge material
DE19750303A1 (de) 1997-11-13 1999-05-20 Henkel Kgaa Verwendung von alkylierten Phenothiazinen zum Färben von keratinhaltigen Fasern
US7229447B1 (en) * 1998-08-25 2007-06-12 Advanced Photodynamics Technologies, Inc. Photodynamic therapy utilizing a solution of photosensitizing compound and surfactant
US6562295B1 (en) * 1999-06-30 2003-05-13 Ceramoptec Industries, Inc. Bacteria resistant medical devices
JP2001124699A (ja) 1999-10-28 2001-05-11 Miura Co Ltd 溶存酸素濃度測定用指示薬
JP2003531828A (ja) * 2000-02-26 2003-10-28 アドバンスト フォトダイナミック テクノロジーズ, インコーポレイテッド 光感光性物質および界面活性剤を使用する、光力学的な細胞および無細胞生物の根絶
WO2001070699A1 (fr) 2000-03-22 2001-09-27 Bf Research Institute, Inc. Analogues d'azur a utilises comme sondes dans l'imagerie diagnostique des maladies dues a l'accumulation d'amyloide, et compositions renfermant ces analogues destinees a l'imagerie diagnostique
CA2408332C (en) * 2000-05-08 2011-02-15 The University Of British Columbia Supports for photosensitizer formulations
US6551346B2 (en) * 2000-05-17 2003-04-22 Kent Crossley Method and apparatus to prevent infections
FR2810318B1 (fr) * 2000-06-15 2005-09-23 Laurent Galey Derives de diamano-phenothiazine
WO2002089750A2 (en) * 2001-01-19 2002-11-14 Advanced Photodynamic Technologies, Inc. Apparatus and method of photodynamic eradication of organisms utilizing pyrrolnitrin
GB2373787A (en) 2001-03-08 2002-10-02 Univ Central Lancashire Phenothiazinium derivatives and their use to reduce pathogenic contaminants
GB0106953D0 (en) * 2001-03-20 2001-05-09 Univ Aberdeen Neufofibrillary labels
GB0113121D0 (en) 2001-05-30 2001-07-18 Univ Leeds Biologically active photosensitisers
IL159894A0 (en) * 2001-07-17 2004-06-20 Res Dev Foundation Therapeutic agents comprising pro-apoptotic proteins
US6551171B1 (en) * 2002-01-24 2003-04-22 Brian Hass Brassiere with detachable uniform pressure assembly
US7176308B2 (en) * 2002-06-17 2007-02-13 Verification Technologies, Inc. Processes for preparing novel methylene blue derivative
US6952392B2 (en) * 2002-06-17 2005-10-04 Verification Technologies, Inc. Laser reactive dyes for DVD copy protection system
GB0420888D0 (en) * 2004-09-20 2004-10-20 Photopharmica Ltd Compounds and uses
US7220879B2 (en) * 2004-10-01 2007-05-22 Rohm And Haas Company Method for inhibiting polymerization of (meth)acrylic acid and its esters using an inhibitor and a process for making a compound useful as such an inhibitor

Similar Documents

Publication Publication Date Title
JP2005500271A5 (ja)
US7915254B2 (en) Biologically active methylene blue derivatives
Khurana et al. Hydrogels: soft matters in photomedicine
Carpenter et al. Synthesis, characterization, and antimicrobial efficacy of photomicrobicidal cellulose paper
KR20060111536A (ko) 생물학적 활성 메틸렌 블루 유도체(2)의 개발
Craig et al. Photosensitisers–the progression from photodynamic therapy to anti-infective surfaces
AU2002256784A1 (en) Biologically active methylene blue derivatives
US20090248146A1 (en) Coatings for implantable medical devices
US7407948B2 (en) Photosensitisers and their uses
Cui et al. Molecular engineering of antimicrobial peptide (AMP)–polymer conjugates
JP2009500462A (ja) 自己滅菌性製品
ZA200604309B (en) Developments in biologically active methylene blue derivatives (2)
JP2022541257A (ja) 光増感剤、機能性ポリマー材料による機能性ポリマー表面の取得方法及びその用途
GB2373787A (en) Phenothiazinium derivatives and their use to reduce pathogenic contaminants
Pierau et al. Light and Hydrogels: A New Generation of Antimicrobial Materials. Materials 2021, 14, 787
ES2416710T3 (es) Productos autoesterilizantes
MXPA06005792A (en) Developments in biologically active methylene blue derivatives (2)